Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

S. Gallego, I. Zanetti, D. Orbach, D. Ranchère, J. Shipley, A. Zin, C. Bergeron, G.L. de Salvo, J. Chisholm, A. Ferrari, M. Jenney, H.C. Mandeville, T. Rogers, J.H.M. Merks, P. Mudry, H. Glosli, G.M. Milano, S. Ferman, G. Bisogno

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)3201-3209
Number of pages9
JournalCancer
Volume124
Issue number15
DOIs
Publication statusPublished - 2018

Cite this

Gallego, S., Zanetti, I., Orbach, D., Ranchère, D., Shipley, J., Zin, A., Bergeron, C., de Salvo, G. L., Chisholm, J., Ferrari, A., Jenney, M., Mandeville, H. C., Rogers, T., Merks, J. H. M., Mudry, P., Glosli, H., Milano, G. M., Ferman, S., & Bisogno, G. (2018). Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancer, 124(15), 3201-3209. https://doi.org/10.1002/cncr.31553